HIV/AIDS care in Africa today

Clinical Infectious Diseases

Volumn 40, Issue 7, 2005, Pages 1045-1048

  Ronald, Allan R ^a,b,d   Sande, Merle A ^b,c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MAKERERE UNIVERSITY   (Uganda)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Acad Alliance Found AIDS Care P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; DRUG COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; NOTE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

AFRICA; AMBULATORY CARE; DELIVERY OF HEALTH CARE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS;

EID: 15744379494     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428360     Document Type: Note

References (7)

1. Hogg R, Cahn P, Katabira E, Lange J. Time to act: global apathy towards HIV/AIDS is a crime against humanity. Lancet 2002; 360:1710-1.
2. World Health Organization (WHO)/Joint United Nations Programme on HIV/AIDS (UNAIDS). Treating 3 million by 2005: making it happen. The WHO strategy. France: WHO/AIDS, 2003. Available at: http://www.who.int/3by5/ publications/documents/isbn9241591129 /en/. Accessed 23 February 2005.
3. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. ART Cohort Collaboration. Lancet 2002; 360:119-29.
4. Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science 2004; 304:714-8.
5. Wester CW, Bussmann H, Avalos A, et al. Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned. Clin Infect Dis 2005; 40:1041-4 (in this issue).
6. Gayle HD. Curbing the global AIDS epidemic. N Engl J Med 2003; 348:1802-5.
7. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36:1100-2.